Trump's Tariff Threats on Pharmaceuticals and Generics
Former US President Trump's administration is threatening significant tariffs, including a 100% levy on Indian generics and a 50% tariff on Canadian goods. These threats are causing concern among drugmakers and could be a negotiation tactic.
The Story
Analyzing sources…
Source Diversity
Source Diversity
High (67/100)Sources
Premiers looking for a tariff battle plan from Carney during sit-down in P.E.I.
Canada's premiers are sitting down with Prime Minister Mark Carney Thursday in Charlottetown, where they say they're hoping for more insight into how he plans to negotiate with U.S. President Donald Trump.
Read full article →Trump's 50% Tariff Threat May Hurt Canada But Could Be Negotiation Tactic: Experts
Desjardins economist Randall Bartlett estimates the tariffs could shave two to three tenths of a percent off Canada's growth in 2026 and 2027.
Read full article →Indian drugmakers rattled by Trump’s 100% levy on generics
The U.S. president says non-patented drugmakers would have two years to move production to the U.S. or face a 100% import tariff, which would double a year later.
Read full article →
